Advanced search
Publication Cover
Journal of Medical Economics Volume 18, 2015 - Issue 8
Submit an article Journal homepage
1,515
Views
10
CrossRef citations to date
0
Altmetric
Original research

Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway

Pernilla HuetsonIMS Health, Stockholm, Sweden
,
James L. PalmerIMS Health, Basel, Switzerland
,
Andrée LevorsenSanofi, Norway
,
Marie FournierSanofi, Paris, FranceCorrespondence[email protected]
,
Maeva GermeSanofi, Paris, France
&
Euan McLeodIMS Health, London, United Kingdom
Pages 573-585 | Accepted 02 Apr 2015, Published online: 01 Jun 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.